Metraipolis › archive › dc_dc12277ac427

MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma — Europe PMC PMID:42337173

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42337173
DOI
10.1186/s43556-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-19T04:20:05.130Z
SHA-256 of the archived text
5ef57d3a770ef86d4da2fd92a533b25d9383aa61f285bec227e39315d26b4232
Stable URL of this page
https://metraipolis.com/documento/dc_dc12277ac427

How to cite

MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma — Europe PMC PMID:42337173 — Europe PMC (en), https://europepmc.org/article/MED/42337173 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc12277ac427 (Metraipolis archive dc_dc12277ac427, sha256 5ef57d3a770ef86d4da2fd92a533b25d9383aa61f285bec227e39315d26b4232)
BibTeX
@misc{dcdc12277ac427,
  title = {MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma — Europe PMC PMID:42337173},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42337173},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc12277ac427; sha256 5ef57d3a770ef86d4da2fd92a533b25d9383aa61f285bec227e39315d26b4232},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42337173. Agents can read the archived copy with the MCP tool read_document.